1-hexadecyl-2-acetyl-glycero-3-phosphocholine and piroxicam

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with piroxicam in 2 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (piroxicam)	Trials (piroxicam)	Recent Studies (post-2010) (piroxicam)
9,156	187	552	3,084	796	704

Protein Interaction Comparison

Protein	Taxonomy	piroxicam (IC50)
Prostaglandin G/H synthase 1	Homo sapiens (human)	1.3043
Prostaglandin G/H synthase 2	Rattus norvegicus (Norway rat)	0.1
Prostaglandin G/H synthase 1	Rattus norvegicus (Norway rat)	0.1

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Conklyn, M; Showell, HJ; Watson, JW	1
Andersson, J; Bengtsson, T; Grenegård, M; Kälvegren, H	1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and piroxicam

Article	Year
IgG1-mediated acute pulmonary hypersensitivity response in the guinea pig. Involvement of specific lipid mediators. The American review of respiratory disease, 1990, Volume: 142, Issue:5 Topics: Acute Disease; Animals; Azepines; Bronchoconstriction; Dicarboxylic Acids; Dose-Response Relationship, Drug; Furans; Guinea Pigs; Immunization; Immunoglobulin G; Indoles; Lipids; Lung; Male; Ovalbumin; Phenylcarbamates; Piroxicam; Platelet Activating Factor; Propranolol; Pyrilamine; Respiratory Hypersensitivity; SRS-A; Sulfonamides; Tosyl Compounds; Triazoles	1990
Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors. European journal of pharmacology, 2007, Jul-02, Volume: 566, Issue:1-3 Topics: Adenosine Triphosphate; Adult; Aspirin; Caffeic Acids; Cell Line, Tumor; Chlamydophila pneumoniae; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Flavanones; Humans; Lipoxygenase Inhibitors; Piroxicam; Platelet Activating Factor; Platelet Aggregation; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12	2007

Article

Year

IgG1-mediated acute pulmonary hypersensitivity response in the guinea pig. Involvement of specific lipid mediators.

The American review of respiratory disease, 1990, Volume: 142, Issue:5

Topics: Acute Disease; Animals; Azepines; Bronchoconstriction; Dicarboxylic Acids; Dose-Response Relationship, Drug; Furans; Guinea Pigs; Immunization; Immunoglobulin G; Indoles; Lipids; Lung; Male; Ovalbumin; Phenylcarbamates; Piroxicam; Platelet Activating Factor; Propranolol; Pyrilamine; Respiratory Hypersensitivity; SRS-A; Sulfonamides; Tosyl Compounds; Triazoles

1990

Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors.

European journal of pharmacology, 2007, Jul-02, Volume: 566, Issue:1-3

Topics: Adenosine Triphosphate; Adult; Aspirin; Caffeic Acids; Cell Line, Tumor; Chlamydophila pneumoniae; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Flavanones; Humans; Lipoxygenase Inhibitors; Piroxicam; Platelet Activating Factor; Platelet Aggregation; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12

2007